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The aim of our study was to use a modified Delphi process to determine the research 
priorities among benign upper gastrointestinal (UGI) surgeons in the United Kingdom. 
 
Methods 
Delphi methodology may be utilised to develop consensus opinion amongst a group of 
experts. Members of the Association of Upper Gastrointestinal Surgeons of Great Britain 
and Ireland were invited to submit individual research questions via an online survey (phase 
I). Two rounds of prioritisation by multidisciplinary expert healthcare professionals (phase II 
and III) were completed to determine a final list of high priority research questions. 
 
Results 
427 questions were submitted in phase I and 51 with a benign UGI focus were taken 
forward for prioritisation in phase II. 28 questions were ranked in phase III. A final list of 11 
high priority questions had an emphasis on acute pancreatitis, Barrett’s oesophagus and 
benign biliary disease. 
 
Conclusion 
A modified Delphi process has produced a list of 11 high priority research questions in 
benign UGI surgery. Future studies and awards from funding bodies should reflect this 
consensus list of prioritised questions in the interest of improving patient care and 




The scope of benign upper gastrointestinal (UGI) surgery is broad and includes the 
management of common conditions such as; cholelithiasis, pancreatitis, Barrett’s 
oesophagus and gastro-oesophageal reflux disease. Other conditions may be encountered 
less frequently; paraoesophageal hernia, gastric volvulus, achalasia and oesophageal 
dysmotility. Not all of these conditions require operative intervention but each of them may 
require input from an UGI surgeon with a benign subspecialty interest. An evidence based 
approach is the ideal way to manage patients with these conditions, but a significant 
proportion of benign UGI practice lacks an evidence base.  
 
A modified Delphi process can be used to develop a list of priorities by consensus from a 
group of experts. This has been successfully utilised in colorectal surgery (1), orthopaedics 
(2) plastic surgery (3) and hepatobiliary surgery (4). This approach in determining research 
priorities improves efficiency and adds greater value to those who fund benign UGI surgery 
research (5). 
 
To our knowledge no attempt has previously been made to determine the future research 
priorities in benign UGI surgery. The aim of our study was to undertake a modified Delphi 
process to determine the research priorities in benign UGI surgery. 
  
 4 
Material and Methods 
A three-phased modified Delphi process was undertaken (Figure 1). This included two 
distinct phases of prioritisation by expert multidisciplinary stakeholders utilising established 
methodology, as previously described for a number of clinical projects (1, 6, 7). Stakeholders 
were asked to submit questions and, thereafter, prioritise their responses based upon their 
own perceived clinical need. During the prioritisation phases (II and III), only complete 
submissions where all questions were ranked were included in the analysis. 
 
Phase I 
Experts were recruited from the Association of Upper GI Surgeons of Great Britain and 
Ireland (AUGIS) membership, which includes medical professionals and members of the 
wider multidisciplinary team such as research nurses, dietitians and specialist nurses. 
Members were invited by email to submit research questions across the entire spectrum of 
UGI and hepato-pancreato-biliary (HPB) surgery (including both benign and malignant 
conditions) via an online survey (http://surveymonkey.com). The social media platform 
Twitter was also used to broaden the awareness of the Delphi process amongst interested 
stakeholders. There was no limit on the number of research questions that an individual 
could submit. The survey was open to submissions for 3 month, with three email reminders 
sent to the AUGIS membership during this period. 
 
Submitted questions were collated and then grouped into four categories: 1) HPB; 2) Benign 
UGI; 3) Malignant oesophagogastric (OG); and 4) Bariatric and metabolic surgery. Any 
disagreements regarding categorisation were resolved by consensus. 
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To assess category (2) above, a benign UGI surgery steering committee was formed. 
Duplicate questions were removed. Questions with a similar theme were altered by 
consensus agreement of the steering committee. Care was taken not to alter the meaning 
of the reviewed questions. 
 
Phase II 
Benign UGI surgery research questions were prioritised by AUGIS members by email 
invitation with a link to an online survey (Google forms). Twitter was again used to highlight 
the prioritisation process amongst interested stakeholders. The survey contained all of the 
Benign UGI surgery research questions and respondents were asked to prioritise each 
question using a Likert scale (1 – lowest priority to 5 – highest priority). The survey remained 
open to submissions for 11 weeks with three email reminders sent to AUGIS members. The 
results were reviewed by the steering committee and a ‘cut-off’ point agreed by consensus 




A final round of prioritisation was performed after AUGIS members were again invited by 
email and Twitter to follow a link to a Google forms survey and prioritise the questions using 
the same Likert scale as in Phase II. The survey remained open for 7 weeks and three email 
reminders were sent. Results were reviewed by the steering committee to identify the final 
list of prioritised questions. The criteria for inclusion in the final list of research priorities 
was a mean score of ≥3.5, a Likert score of 4-5 by >50% respondents and a Likert score of 1-




The benign UGI surgery steering committee consisted of one Upper GI senior surgical 
trainee (MW), five consultant upper GI surgeons (SO, EG, RS, SA and PL) and lay 
representation (CB, GY). The overall role of the steering committee was to ensure relevance 






Four hundred and twenty seven research questions were submitted by 140 AUGIS members 
in Phase I, representing 47.6% of the membership (Figure 2). Of those responding, a sub-
specialisation benign UGI surgery interest was declared by 68 (48.6%). 
Once duplicated and similar questions were reviewed and amended or removed by 
consensus agreement, 51 questions were moved forward for prioritisation in phase II. Sixty-
nine stakeholders voluntarily prioritised the questions in phase II. An analysis of the 
prioritisation was performed by the steering committee and consensus reached regarding a 
cut-off for inclusion (mean ≥3.0) in phase III. 
 
Twenty-eight questions were included in the final phase of prioritisation and 65 surgical 
stakeholders took part. Following review by the steering committee with consensus 
agreement on the criteria for inclusion on the final list of clinical priorities as detailed in the 
methods section, 11 questions were included on the final list of benign UGI surgery 
questions with high research priority (Figure 3). Our list of prioritised questions focused on 
the following themes; 
1) Acute pancreatitis 
2) Barrett’s oesophagus (BE) 
3) Benign biliary disease 
4) Other – achalasia, GERD, hiatus hernia 
The questions which failed to make the final list of research priorities from phase III can be 





This study has produced a list of 11 high priority research questions relevant to the surgical 
subspecialty of benign UGI surgery using a modified Delphi process. To our knowledge this is 
the first time that such a project has been undertaken in the field of benign Upper GI 
surgery. This study was undertaken as part of a wider project to determine the research 
priorities in the broader specialty of Upper GI surgery (which also incorporated the 
subspecialty interests of bariatric and metabolic surgery, HPB (4) and malignant 
oesophagogastric surgery). 
 
From our list of prioritised questions there is an emphasis on focusing future research on 
the management of acute pancreatitis, Barrett’s oesophagus (BE) and benign biliary disease. 
Our final list also included questions relating to the management of GERD, hiatus hernia 
repair and achalasia.  
 
The emphasis on acute pancreatitis may be unsurprising as it is frequently encountered 
during the acute general surgery take and can lead to significant morbidity and difficult 
management decisions (8). Three questions relating to acute pancreatitis ranked sufficiently 
to be included in our final list of research priorities. Hospital readmissions as a result of 
pancreatitis can be as high as 17% (9). Recent evidence suggests an increased incidence of 
pancreatitis among younger patients, reduced incidence in older patients with the most 
common aetiologies being biliary disease and alcohol related (10). A recently published trial 
may have already addressed the question relating to whether patients with idiopathic 
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pancreatitis benefit from a laparoscopic cholecystectomy (11). The authors concluded that 
laparoscopic cholecystectomy if effective for the treatment of recurrent idiopathic 
pancreatitis, although the methodology has subsequently been criticised (12, 13). 
 
BE contributes three questions to our final list of research priorities. The reasons for this are 
unclear. One explanation may be that the majority of UGI surgeons encounter this condition 
in their endoscopic practice, and interest in this condition is likely to be higher amongst 
those with a malignant OG interest. Interest in BE may have been heightened by the recent 
publication of the AspECT trial which reported improved outcomes in those who receive a 
combination of high dose PPI aspirin (14). The inclusion of the questions relating the true 
risk of progression and the surveillance programme for Barrett’s oesophagus are also 
unexpected as they are likely to be answered upon completion of the BOSS trial (15).  The 
BOSS trial is a large UK randomised trial of regular surveillance endoscopy versus on 
demand endoscopies in patients with BE and is due to report in 2022.  Equally, the inclusion 
of the question that relates to the natural history of small stones in the common bile duct 
may also  be addressed in the Sunflower Study (16).  The Sunflower Study is a large 
pragmatic UK randomised trial of pre-operative MRCP versus no imaging in patients with 
low to medium risk of CBD stones have either emergency or elective laparoscopic 
cholecystectomy.   It is currently recruiting in the pilot phase.  
 
The Delphi process of research questions importance to UK surgeons does not measure the 
feasibility of studies, the costs and how they would be funded, the likelihood that a study 
design would effectively or adequately answer the clinical question, nor does the list take in 
to account studies that are already underway that would address the questions posed.  For 
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example the BOSS trial is prospectively following 3,500 patients with Barrett’s oesophagus 
and looking at the relative value of surveillance every 2 years versus at need, and the Aspect 
trial has just reported the outcome of 2,500 patients with Barrett’s oesophagus where the 
dose of PPI with or without aspirin has been assessed for cancer prevention.  In both studies 
the true underlying disease progression of Barrett’s to cancer will be available and in a 
cohort of 6,000 patients with more than 7 years prospective follow up.  These studies will 
answer the related questions highlighted by the Delphi process (5th and 6th questions in 
Figure 3).  
 
The frequency of achalasia is relatively low and so it would be highly unlikely that a UK trial 
could answer the question (9th in Fig 3) on whether laparoscopic Heller’s cardiomyotomy 
with antireflux procedure is superior to per-oral endoscopic myotomy (POEM) but there is 
already a European multi-national study underway looking at these two options (17). One of 
the great difficulties of comparing procedures is the variation in technical training, learning 
curve and the quality of operative skills in different countries and in different surgical 
specialties. Often, the best therapy may not be one particular operation or procedure but 
the one that the institution or clinician is trained to perform and most familiar with.  
 
There has long been a debate regarding the specific technical details regarding antireflux 
surgery.    At its most basic level this could be about whether a Nissen fundoplication is 
better than a partial fundoplication?   However, partial wraps can be anterior or posterior, 
and even amongst these broad categories significant variations in technique exist, including 
formation of the wrap, number of sutures, type of sutures, division of the short gastric 
vessels and closure of the hiatus to name just a few.   In relation to the 10th question in 
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Figure 3 it is the generally held view that the most appropriate anti reflux operation is 
probably the one the individual surgeon and institution has the most experience in 
performing. Prospective research to prove or disprove this is complicated by generalisability 
of any particular clinical trial.  For many years the indications for anti reflux surgery have not 
been standardised, but recent guidelines may help to address this in the future (18).  
 
A number of questions failed to make the final list of prioritised questions (Appendix1) and 
the reasons are likely to be multifactorial. The questions posed may be due to be answered 
by current studies. An example of this would be ‘What is the optimal management of 
asymptomatic choledocholithiasis?’ which is being addressed in the Sunflower study. 
Alternatively, the proposed question may have already been answered. An example of this 
would include ‘what is the optimal time to perform an emergency laparoscopic 
cholecystectomy for acute cholecystitis?’ and ‘is emergency laparoscopic cholecystectomy 
cost effective?’  (19-22). 
 
In the final round of prioritisation, all responses were submitted by surgeons. This is a 
limitation of our study.  A broader range of contributions from the Upper GI 
multidisciplinary team (radiologists, dietitians, specialist nurses) may have been desirable. 
Twitter was used to publicise the existence of the survey, and therefore the survey was in 
the public domain and open to submissions from lay individuals, patients and family 
members. Unfortunately, no submissions were received from non-healthcare professionals. 
We did have lay representation on the committee, both of whom have prior experience of 
Delphi methodology. CB and GY were involved in the discussion and agreement upon 
methodology in phase II and III of the study.      
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Previous Delphi processes in other specialties reported response rates ranging from 11 to 
25%. Our response rate in phase I across all specialties was 47.6% and this should therefore 
be considered as sufficient engagement from the AUGIS membership. The list of prioritised 
research questions will be shared with funding bodies. The expectation is that our list of 
research questions will provide a focus of future research topics and be a useful resource for 
research grant and clinical trial applications. Further, AUGIS members who contributed to 
this study at any point from phase I to II may become motivated to undertake future 
research in to some of the questions identified by this consensus agreed Delphi process.  
 
In summary, our modified Delphi process has produced a list of questions that have been 
deemed by consensus amongst UK benign UGI surgical specialists to have the highest 
research priority in the field of OG cancer surgery. There is an emphasis on acute 
pancreatitis, BE and benign biliary disease. Future research projects should seek to address 
these questions as well as to engage improved patient and public involvement. 
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